141 related articles for article (PubMed ID: 9542594)
1. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.
Husain N; Chiocca EA; Rainov N; Louis DN; Zervas NT
Acta Neuropathol; 1998 Mar; 95(3):287-90. PubMed ID: 9542594
[TBL] [Abstract][Full Text] [Related]
2. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.
Frankel B; Longo SL; Ryken TC
J Neurooncol; 1999; 44(3):205-12. PubMed ID: 10720200
[TBL] [Abstract][Full Text] [Related]
3. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas.
Gutierrez LS; Eliza M; Niven-Fairchild T; Naftolin F; Mor G
Breast Cancer Res Treat; 1999 Apr; 54(3):245-53. PubMed ID: 10445423
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors.
Ichinose M; Masuoka J; Shiraishi T; Mineta T; Tabuchi K
Brain Tumor Pathol; 2001; 18(1):37-42. PubMed ID: 11517972
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.
Gratas C; Tohma Y; Van Meir EG; Klein M; Tenan M; Ishii N; Tachibana O; Kleihues P; Ohgaki H
Brain Pathol; 1997 Jul; 7(3):863-9. PubMed ID: 9217971
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors.
Frankel B; Longo SL; Ryken TC
Acta Neuropathol; 1999 Oct; 98(4):363-6. PubMed ID: 10502041
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy.
Hammer A; Blaschitz A; Daxböck C; Walcher W; Dohr G
Am J Reprod Immunol; 1999 Jan; 41(1):41-51. PubMed ID: 10097786
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between Fas/Fas-ligand expression and apoptosis in undifferentiated nasopharyngeal carcinoma].
Enami A; Tsutsumi K; Kobayashi T; Shibosawa E; Koizuka I
Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1087-92. PubMed ID: 12440162
[TBL] [Abstract][Full Text] [Related]
11. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.
Bernstorff WV; Glickman JN; Odze RD; Farraye FA; Joo HG; Goedegebuure PS; Eberlein TJ
Cancer; 2002 May; 94(10):2552-60. PubMed ID: 12173320
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo.
Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Kim CS; Kim SH; Yoo NJ
APMIS; 1998 Nov; 106(11):1035-40. PubMed ID: 9890264
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
Saas P; Walker PR; Hahne M; Quiquerez AL; Schnuriger V; Perrin G; French L; Van Meir EG; de Tribolet N; Tschopp J; Dietrich PY
J Clin Invest; 1997 Mar; 99(6):1173-8. PubMed ID: 9077524
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis.
Kwon D; Choi C; Lee J; Kim KO; Kim JD; Kim SJ; Choi IH
J Neuroimmunol; 2001 Feb; 113(1):1-9. PubMed ID: 11137571
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
Mitsiades N; Poulaki V; Mastorakos G; Tseleni-Balafouta ST; Kotoula V; Koutras DA; Tsokos M
J Clin Endocrinol Metab; 1999 Aug; 84(8):2924-32. PubMed ID: 10443700
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
Rajashekhar G; Loganath A; Roy AC; Mongelli JM
Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
